Youngjoo Song

  • Senior Advisor
  • T. +82-2-3404-6595
  • F. +82-2-3404-0801
  • E. youngjoo.song@bkl.co.kr

Overview

Youngjoo Song is responsible for providing advice on public policy & life science, pharmaceutical and medical devices, public health, government relations, and risk management, etc. at Bae, Kim & Lee LLC.

Prior to joining BKL, Ms. Song worked for Johnson & Johnson Korea where she, as the head of Government Affairs & Policy, had been in charge of overall management of the public relations and policies of affiliates with respect to pharmaceutical manufacturing, medical devices, consumer goods, and OTC, etc. for more than 12 years.

Ms. Song has acquired vast experience in the fields of public health and health care while working for a media outlet and the government. She started her journalism career as a journalist at the Hankook Ilbo and then advanced to the positions of the head of Living & Science Department, editor, an editorial board member, and a senior medical reporter, etc. She served as the director of the Policy Management and Public Relations Department at the Ministry of Health and Welfare. She also worked as a takemi fellow of the Department of Global Health at the Harvard School of Public Health.

Ms. Song received her B.A., M.P.H. and Ph.D. in Public Health, all from Yonsei University. She joined BKL in 2022.

Representative Experience

2022-Present Bae, Kim & Lee LLC
2009-2021 Head, Government Affairs & Policy, Johnson & Johnson Korea
2008-2009 Takemi Fellow, Harvard T.H. Chan School of Public Health
2005-2008 Director, Policy Management and Public Relations Department, Ministry of Health and Welfare
1999-2005 Senior Medical Reporter, Editorial Board Member, Head of Living & Science Department, Deputy Head of Culture Department, Hankook Ilbo
1985-1998 Journalist, Hankook Ilbo

Representative Matters

Analyzed the pharmaceutical industry at home and abroad and advised on business strategies
Advised on an ex-post facto administration of medicines, such as the Price-Volume Agreement Program and the price reduction of original drugs whose patents expired
Advised on the government's policy to extend the list of reference countries for drug prices
Analyzed and advised concerning the policy environment in respect of overall aspects of digital healthcare, including digital therapeutics and healthcare data
Advised a medical device manufacturer on the listing of its treatment materials for health insurance coverage and an increase of relevant insurance benefits
Analyzed the pharmaceutical industry at home and abroad and advised on business strategies
Represented a healthcare company in proceeding with a project to attract 'innovation offices' to Korea
Represented a drug manufacturer in proceeding with a project to obtain the 'Certification of Innovative Pharmaceutical Companies'
Advised on an ex-post facto administration of medicines, such as the Price-Volume Agreement Program and the price reduction of original drugs whose patents expired
Advised on the government's policy to extend the list of reference countries for drug prices
Analyzed and advised concerning the policy environment in respect of overall aspects of digital healthcare, including digital therapeutics and healthcare data
Advised a medical device manufacturer on the listing of its treatment materials for health insurance coverage and an increase of relevant insurance benefits
Participated in a project to amend the standard for adjustment of the health insurance coverage limit based on an exchange rate peg

Education

2009 Yonsei University (Ph.D.)
2000 Yonsei University (M.P.H.)
1985 Yonsei University (B.A.)

Selected Activities

Publications
Why Women? (Sia Publishing, 2005)
Best Doctors (名醫) (Hankook Ilbo, 1994)
Awards
Yonsei 100 Future Women Leaders (Yonsei Women Alumni Association, 2006)
ACE (Awarding Cancer Enlightenment) Reporter Award (ECCO, 2005)
Woman Journalist of the Year (Korean Women Journalists Association, 2005)
Journalist of the Year (KSJA, 2001)
Green Cross Media Culture Award (Koreas Medical Association, 1994)